Latest News

View allAccessAL amyloidosisCAR-TConferencesMPEMyelomaNewsPatient evidenceSin categoríaVideos

Takeda announces discontinuation of the phase 3 clinical trial TOURMALINE-AL1 in AL amyloidosis

  The pharmaceutical company Takeda announced that the Phase 3 TOURMALINE-AL1 clinical trial in patients with relapsed or refractory AL amyloidosis did not meet the first of two primary endpoints. Treatment with ixazomib in combination with dexamethasone did not demonstrate a significant improvement in overall hematologic response compared to physician’s choice of standard of care…

Read more

ASH 2018 highlights in myeloma

Myeloma Patients Europe held a webinar to review the most recent myeloma findings presented at the annual meeting of the American Society of Hematology (ASH) that took place in San Diego (California, United States) in December 2018.

Read more
June

July 2026

August
MO
TU
WE
TH
FR
SA
SU
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
Events for 1st July
No Events
Events for 2nd July
No Events
Events for 3rd July
No Events
Events for 4th July
No Events
Events for 5th July
No Events
Events for 6th July
No Events
Events for 7th July
No Events
Events for 8th July
No Events
Events for 9th July
No Events
Events for 10th July
No Events
Events for 11th July
No Events
Events for 12th July
No Events
Events for 13th July
No Events
Events for 14th July
No Events
Events for 15th July
No Events
Events for 16th July
No Events
Events for 17th July
No Events
Events for 18th July
No Events
Events for 19th July
No Events
Events for 20th July
No Events
Events for 21st July
No Events
Events for 22nd July
No Events
Events for 23rd July
No Events
Events for 24th July
No Events
Events for 25th July
No Events
Events for 26th July
No Events
Events for 27th July
No Events
Events for 28th July
No Events
Events for 29th July
No Events
Events for 30th July
No Events
Events for 31st July
No Events